Jie Qing - Publications

University of California, Santa Cruz, Santa Cruz, CA, United States 

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Cao L, Chen J, Wang Y, Yang Y, Qing J, Rao Z, Chen X, Lou Z. Identification of serotonin 2A receptor as a novel HCV entry factor by a chemical biology strategy. Protein & Cell. PMID 29542010 DOI: 10.1007/s13238-018-0521-z  0.44
2016 Han Z, Liang X, Wang Y, Qing J, Cao L, Shang L, Yin Z. The discovery of indole derivatives as novel hepatitis C virus inhibitors. European Journal of Medicinal Chemistry. 116: 147-155. PMID 27061978 DOI: 10.1016/j.ejmech.2016.03.062  0.44
2015 Qing J, Luo R, Wang Y, Nong J, Wu M, Shao Y, Tang R, Yu X, Yin Z, Sun Y. Resistance Analysis and Characterization of NITD008 as an Adenosine Analog Inhibitor against Hepatitis C Virus. Antiviral Research. PMID 26724382 DOI: 10.1016/j.antiviral.2015.12.010  0.44
2015 Guo Y, Wang Y, Cao L, Wang P, Qing J, Zheng Q, Shang L, Yin Z, Sun Y. A conserved inhibitory mechanism of a lycorine derivative against enterovirus and hepatitis C virus. Antimicrobial Agents and Chemotherapy. PMID 26596952 DOI: 10.1128/AAC.02274-15  0.44
2015 Yan W, Qing J, Mei H, Nong J, Huang J, Zhu J, Jiang H, Liu L, Zhang L, Li J. Identification, synthesis and pharmacological evaluation of novel anti-EV71 agents via cyclophilin A inhibition. Bioorganic & Medicinal Chemistry Letters. PMID 26564266 DOI: 10.1016/j.bmcl.2015.11.002  0.4
2015 Wang H, Wang S, Cheng L, Chen L, Wang Y, Qing J, Huang S, Wang Y, Lei X, Wu Y, Ma Z, Zhang L, Tang Y. Discovery of Imidazo[1,2-α][1,8]naphthyridine Derivatives as Potential HCV Entry Inhibitor. Acs Medicinal Chemistry Letters. 6: 977-81. PMID 26396683 DOI: 10.1021/acsmedchemlett.5b00159  0.44
2015 Yan W, Qing J, Mei H, Mao F, Huang J, Zhu J, Jiang H, Liu L, Zhang L, Li J. Discovery of Novel Small Molecule Anti-HCV Agents via the CypA Inhibitory Mechanism Using O-Acylation-Directed Lead Optimization. Molecules (Basel, Switzerland). 20: 10342-59. PMID 26053489 DOI: 10.3390/molecules200610342  0.4
2015 Luo K, Li S, Jiang L, Zuo T, Qing J, Shi X, Liu Y, Wu H, Chen X, Zhang L. Combinatorial library-based profiling of the antibody response against hepatitis C virus in humans. The Journal of General Virology. 96: 52-63. PMID 25274855 DOI: 10.1099/vir.0.069278-0  0.4
2014 Shang L, Wang Y, Qing J, Shu B, Cao L, Lou Z, Gong P, Sun Y, Yin Z. An adenosine nucleoside analogue NITD008 inhibits EV71 proliferation. Antiviral Research. 112: 47-58. PMID 25446894 DOI: 10.1016/j.antiviral.2014.10.009  0.44
2014 Qing J, Wang Y, Sun Y, Huang J, Yan W, Wang J, Su D, Ni C, Li J, Rao Z, Liu L, Lou Z. Cyclophilin A associates with enterovirus-71 virus capsid and plays an essential role in viral infection as an uncoating regulator. Plos Pathogens. 10: e1004422. PMID 25275585 DOI: 10.1371/journal.ppat.1004422  0.44
2014 Huang S, Qing J, Wang S, Wang H, Zhang L, Tang Y. Design and synthesis of imidazo[1,2-α][1,8]naphthyridine derivatives as anti-HCV agents via direct C-H arylation. Organic & Biomolecular Chemistry. 12: 2344-8. PMID 24595428 DOI: 10.1039/c3ob42525h  0.4
2014 Wang Y, Qing J, Sun Y, Rao Z. Suramin inhibits EV71 infection. Antiviral Research. 103: 1-6. PMID 24374150 DOI: 10.1016/j.antiviral.2013.12.008  0.44
2013 Cui HK, Qing J, Guo Y, Wang YJ, Cui LJ, He TH, Zhang L, Liu L. Stapled peptide-based membrane fusion inhibitors of hepatitis C virus. Bioorganic & Medicinal Chemistry. 21: 3547-54. PMID 23490158 DOI: 10.1016/j.bmc.2013.02.011  0.4
Show low-probability matches.